InvestorsHub Logo
Followers 0
Posts 1610
Boards Moderated 0
Alias Born 03/14/2013

Re: None

Wednesday, 07/01/2015 7:29:01 AM

Wednesday, July 01, 2015 7:29:01 AM

Post# of 704228
What do they know?

I am sure there will be many on message boards that will embrace this and run with it. I am sticking to my 20k+ shares until PHIII results come out at the very least.

http://www.americantradejournal.com/northwest-biotherapeutics-inc-nasdaqnwbo-analyst-rating-update/623588/

Northwest Biotherapeutics (NASDAQ:NWBO) has received a sell rating for the short term, according to the latest rank of 4 from research firm, Zacks. The company received an average rating of 1 from 1 analysts. 1 have rated it as a strong buy.

Northwest Biotherapeutics, Inc. is up 34.74% in the last 3-month period. Year-to-Date the stock performance stands at 85.61%. Northwest Biotherapeutics, Inc. has dropped 3.31% in the last five trading days, however, the shares have posted positive gains of 16% in the last 4 weeks.

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) rose 3.12% or 0.3 points on Tuesday and made its way into the gainers of the day. After trading began at $9.62 the stock was seen hitting $9.94 as a peak level and $9.44 as the lowest level. The stock ended up at $9.93. The daily volume was measured at 627,197 shares. The 52-week high of the share price is $10.79 and the 52-week low is $3.79. The company has a market cap of $764 million.

Currently the company Insiders own 46.94% of Northwest Biotherapeutics, Inc. Company shares. In the past six months, there is a change of 0.63% in the total insider ownership. Institutional Investors own 25.2% of Company shares. During last 3 month period, 2.22% of total institutional ownership has changed in the company shares.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News